Average Co-Inventor Count = 5.54
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (10 from 2,076 patents)
2. Proteostasis Therapeutics, Inc. (6 from 24 patents)
3. Other (1 from 832,680 patents)
4. Ortho-mcneil Pharmaceutical Corp. (1 from 363 patents)
5. Kineta, Inc. (1 from 14 patents)
19 patents:
1. 12319698 - Proteasome activity enhancing compounds
2. 11560385 - Proteasome activity enhancing compounds
3. 11248010 - Compounds, compositions, and methods for modulating CFTR
4. 11136313 - Compounds, compositions, and methods for modulating CFTR
5. 10899751 - Compounds, compositions, and methods for increasing CFTR activity
6. 10662207 - Compounds, compositions, and methods for modulating CFTR
7. 10550106 - Compounds, compositions, and methods for modulating CFTR
8. 10118900 - Benzimidazole derivatives useful as CB-1 inverse agonists
9. 9718820 - Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators
10. 9409915 - Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
11. 9249163 - PDE10a inhibitors for the treatment of type II diabetes
12. 9193736 - PDE 10a inhibitors for the treatment of type II diabetes
13. 9023846 - Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
14. 8680098 - Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
15. 8232409 - Heterocyclic benzimidazoles as TRPM8 modulators